REGULATING PHARMACEUTICAL BUSINESS INTEGRATION – REGULATORY FRAMEWORKS AND IMPACT ON THE HEALTHCARE SYSTEM

Abstract

The regulation of pharmaceutical activities is essential for ensuring public health, structuring the market, and defining access to medicinal products. One of the key aspects is the restriction of integration, which aims to maintain the independence of services and reduce the influence of commercial interests. Countries adopt different approaches to regulating integration in the pharmaceutical sector. Some strictly prohibit manufacturers and wholesale distributors from owning or managing pharmacies to prevent conflicts of interest and potential influence on the prescribing process. On the other hand, some countries follow a more liberal model, allowing large corporations and network organizations to participate in pharmacy management. This approach promotes economies of scale and enables the development of network structures; however, there is a significant risk that commercial interests may take precedence over patient needs. This article analyzes various regulatory models of vertical and horizontal integration.